Bradley Brasher

1.3k total citations
14 papers, 754 citations indexed

About

Bradley Brasher is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Bradley Brasher has authored 14 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Genetics. Recurrent topics in Bradley Brasher's work include Ubiquitin and proteasome pathways (7 papers), Hepatitis C virus research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Bradley Brasher is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Hepatitis C virus research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Bradley Brasher collaborates with scholars based in United States, Canada and Germany. Bradley Brasher's co-authors include Richard A. Van Etten, S. A. Roumiantsev, Neil P. Shah, M. Gorre, Charles L. Sawyers, John Nicoll, Carsten Schwerdtfeger, Wenjian Gan, Ming Xu and Arthur V. Hauenstein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Bradley Brasher

14 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bradley Brasher United States	9	439	334	216	165	147	14	754
Meng Ling Choong Singapore	14	693 1.6×	265 0.8×	284 1.3×	168 1.0×	66 0.4×	24	1.0k
Annamaria Galietta Italy	6	434 1.0×	441 1.3×	309 1.4×	143 0.9×	172 1.2×	8	836
Kathy Rocha United States	7	1.1k 2.5×	368 1.1×	169 0.8×	261 1.6×	49 0.3×	13	1.3k
Vera Magistroni Italy	13	336 0.8×	408 1.2×	295 1.4×	146 0.9×	173 1.2×	23	783
Stephane Wong United States	11	349 0.8×	495 1.5×	339 1.6×	139 0.8×	179 1.2×	15	802
Michael Pranpat United States	6	1.1k 2.5×	252 0.8×	121 0.6×	251 1.5×	49 0.3×	11	1.3k
Mohammad Azam United States	18	694 1.6×	856 2.6×	664 3.1×	318 1.9×	363 2.5×	36	1.6k
Judy Young United States	13	589 1.3×	447 1.3×	275 1.3×	210 1.3×	54 0.4×	20	1.1k
Christian Kardinal Germany	16	560 1.3×	158 0.5×	100 0.5×	187 1.1×	33 0.2×	30	920
Wolfgang Warsch Austria	14	381 0.9×	637 1.9×	427 2.0×	415 2.5×	159 1.1×	16	1.2k

Countries citing papers authored by Bradley Brasher

Since Specialization

Citations

This map shows the geographic impact of Bradley Brasher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley Brasher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley Brasher more than expected).

Fields of papers citing papers by Bradley Brasher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley Brasher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley Brasher. The network helps show where Bradley Brasher may publish in the future.

Co-authorship network of co-authors of Bradley Brasher

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley Brasher. A scholar is included among the top collaborators of Bradley Brasher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley Brasher. Bradley Brasher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Paulo, João A., et al.. (2021). Proteomics of broad deubiquitylase inhibition unmasks redundant enzyme function to reveal substrates and assess enzyme specificity. Cell chemical biology. 28(4). 487–502.e5. 13 indexed citations

Seetharaman, Ashwin, Joan Teyra, Taras Makhnevych, et al.. (2019). Yeast Two-Hybrid Analysis for Ubiquitin Variant Inhibitors of Human Deubiquitinases. Journal of Molecular Biology. 431(6). 1160–1171. 5 indexed citations

Teyra, Joan, Alex U. Singer, Frank W. Schmitges, et al.. (2019). Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15. Structure. 27(4). 590–605.e5. 43 indexed citations

Hewings, David S., Johanna Heideker, P. Taylur, et al.. (2018). Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. Nature Communications. 9(1). 1162–1162. 71 indexed citations

Liu, Pengda, Wenjian Gan, Siyuan Su, et al.. (2018). K63-linked polyubiquitin chains bind to DNA to facilitate DNA damage repair. Science Signaling. 11(533). 73 indexed citations

Owens, Christopher M., Bradley Brasher, Xiaowen Peng, et al.. (2016). Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239. Antimicrobial Agents and Chemotherapy. 60(10). 6207–6215. 3 indexed citations

Owens, Christopher M., Bradley Brasher, Kelly A. Wong, et al.. (2016). Preclinical and Clinical Resistance Profile of EDP-239, a Novel Hepatitis C Virus NS5A Inhibitor. Antimicrobial Agents and Chemotherapy. 60(10). 6216–6226. 3 indexed citations

Békés, Miklós, Keiji Okamoto, Sarah B. Crist, et al.. (2013). DUB-Resistant Ubiquitin to Survey Ubiquitination Switches in Mammalian Cells. Cell Reports. 5(3). 826–838. 38 indexed citations

Jiang, Likun, et al.. (2011). 1213 A HIGHLY POTENT HCV NS5A INHIBITOR EDP-239 WITH FAVORABLE PRECLINICAL PHARMACOKINETICS. Journal of Hepatology. 54. S479–S479. 3 indexed citations

10.

Jiang, Lijuan, Yanbo Gai, Timothy Middleton, et al.. (2009). 8 POTENT HCV PROTEASE INHIBITORS WITH THE POTENTIAL FOR ONCE-DAILY DOSING AND BROAD GENOTYPE COVERAGE. Journal of Hepatology. 50. S6–S6. 2 indexed citations

11.

Vincent, Sylvie, Abraham Thomas, Bradley Brasher, & John D. Benson. (2003). Targeting of proteins to membranes through hedgehog auto-processing. Nature Biotechnology. 21(8). 936–940. 22 indexed citations

12.

Roumiantsev, S. A., Neil P. Shah, M. Gorre, et al.. (2002). Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop. Proceedings of the National Academy of Sciences. 99(16). 10700–10705. 211 indexed citations

13.

Brasher, Bradley, S. A. Roumiantsev, & Richard A. Van Etten. (2001). Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain. Oncogene. 20(53). 7744–7752. 39 indexed citations

14.

Brasher, Bradley & Richard A. Van Etten. (2000). c-Abl Has High Intrinsic Tyrosine Kinase Activity That Is Stimulated by Mutation of the Src Homology 3 Domain and by Autophosphorylation at Two Distinct Regulatory Tyrosines. Journal of Biological Chemistry. 275(45). 35631–35637. 228 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact